Page last updated: 2024-10-14

1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene

Description

1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11271730
MeSH IDM0547740

Synonyms (15)

Synonym
B3465
244187-81-3
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene
1,3-bis[2,6-bis(propan-2-yl)phenyl]-3h-1??-imidazol-1-ylium-2-ide
AKOS016000530
SC11694
1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene;1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2h-imidazol-2-ylidene;1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene;ipr
1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene
1,3-bis(2,6-diisopropylphenyl)-1h-imidazol-3-ium-2-ide
1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2h-imidazol-2-ylidene, 97%
DTXSID10460737
1,3-bis[2,6-di(propan-2-yl)phenyl]-1h-imidazol-3-ium-2-ide
AS-69541
1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-1h-imidazol-2-ylidene
1,3-bis[2,6-di(propan-2-yl)phenyl]-2h-imidazol-1-ium-2-ide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]